PepGen Inc.

PepGen Inc.

World Rank (Jan-05-2024)
18,296
Market Cap (Jan-05-2024)
0.186 Billion USD
World Rank (Jul-30-2023)
19,669
Market Cap (Jul-30-2023)
0.147 Billion USD
World Rank (Jan-07-2022)
18,400
Headquarters Country
USA
Nasdaq / NYSE Code
PEPG
Market Cap (Mar-08-2026)
0.39
World Region
Americas
World Subregion
Northern America
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
PEPGEN INC.
Company Profile
PepGen Inc is a clinical stage biotechnology company focused on advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The headquarters is in Massachusetts.
Founded Year
2018
IPO Year
2022
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share